Picture of Danaher logo

DHR Danaher Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Danaher, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K8-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6,4337,2094,7643,8993,614
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items4156076276351,074
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-429-960811285-279
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities8,3588,5197,1646,6886,416
Capital Expenditures-1,294-1,152-1,383-1,392-1,156
Purchase of Fixed Assets
Other Investing Cash Flow Items-11,693-1,082-5,698-589-40
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-12,987-2,234-7,081-1,981-1,196
Financing Cash Flow Items-112-952,106-131-125
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,295-2,570-273-8,385-2,961
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3,4493,409-131-3,7862,537